Skip to main content
logo
Orion Oyj (HEL:ORNBV)
Finland flag Finland · Delayed Price · Currency is EUR
67.10
+0.55 (0.83%)
Aug 13, 2025, 1:45 PM EET

Ligand Pharmaceuticals Revenue

Orion Oyj had revenue of 416.50M EUR in the quarter ending June 30, 2025, with 26.90% growth. This brings the company's revenue in the last twelve months to 1.68B, up 33.19% year-over-year. In the year 2024, Orion Oyj had annual revenue of 1.54B with 29.65% growth.

Revenue (ttm)
1.68B
Revenue Growth
+33.19%
P/S Ratio
5.58
Revenue / Employee
453.16K
Employees
3,880
Market Cap
9.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.54B352.70M29.65%
Dec 31, 20231.19B-150.90M-11.26%
Dec 31, 20221.34B299.60M28.78%
Dec 31, 20211.04B-37.10M-3.44%
Dec 31, 20201.08B27.10M2.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Terveystalo Oyj1.32B
Revenio Group Oyj107.32M
Pihlajalinna Oyj699.52M
Oriola Oyj1.81B
Nightingale Health Oyj4.95M
Nexstim10.21M
Aiforia Technologies Oyj2.85M
Nanoform Finland Oyj3.94M
Revenue Rankings

Orion Oyj News

More News